Lastest Insider Transactions Of Neoleukin Therapeutics, Inc. ( NLTX )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
NLTXNeoleukin Therapeutics, Inc.BAKER BROS. ADVISORS LPDirectior 10% Owner2023-08-15Buy2,285,3420.641,463,4872023-08-17 17:08:02
NLTXNeoleukin Therapeutics, Inc.Smith Sean MichaelInterim CFO, Prin Acct Off2023-08-10Sell1,3230.628182023-08-14 16:06:55
NLTXNeoleukin Therapeutics, Inc.Smith Sean MichaelInterim CFO, Prin Acct Off2023-08-10Option Exercise5,0000.0002023-08-14 16:06:55
NLTXNeoleukin Therapeutics, Inc.Patel Priti2023-03-31Sell3,7690.692,6082023-04-04 20:51:03
NLTXNeoleukin Therapeutics, Inc.Patel Priti2023-03-31Option Exercise10,0000.0002023-04-04 20:51:03
NLTXNeoleukin Therapeutics, Inc.Smith Sean MichaelPrincipal Accounting Officer2023-02-01Sell3,3160.601,9802023-02-03 16:33:55
NLTXNeoleukin Therapeutics, Inc.Smith Sean MichaelPrincipal Accounting Officer2023-02-01Option Exercise12,5000.0002023-02-03 16:33:55
NLTXNeoleukin Therapeutics, Inc.Patel PritiChief Medical Officer2023-02-01Option Exercise35,0000.0002023-02-03 16:32:55
NLTXNeoleukin Therapeutics, Inc.Patel PritiChief Medical Officer2023-02-01Sell14,3800.608,5882023-02-03 16:32:55